Pfizer and BioNTech on Monday said trial results showed their coronavirus vaccine was safe and produced a robust immune response in children aged five to 11, adding that they would seek regulatory approval shortly.

Covid-19 vaccine makers BioNTech and Pfizer on Wednesday said they had found a South African partner to produce their jab on the African continent for the first time. The move comes amid growing criticism of vaccine inequality that has seen poor countries fall behind richer ones in the race to protect people from the coronavirus.…

The South African Sports Confederation and Olympic Committee (SASCOC) has confirmed that it has agreed to take up an International Olympic Committee (IOC) offer of Pfizer-BioNTech dose of the vaccine, reports insidethegames.biz.

The US Food and Drug Administration (FDA) on Monday authorized the use of the Pfizer-BioNTech Covid-19 vaccine for children aged 12 to 15 years old.

The EU's internal markets commissioner Thierry Breton hinted Sunday that the bloc might decide not to order AstraZeneca's coronavirus jab again following delays in delivering the first batches of the vaccine.

More reasons have emerged why Nigeria cannot have enough COVID-19 vaccines to reach the proposed 70 per cent of its population by the end of next year.

The Philippines received 600,000 vaccine doses from China Sunday, kickstarting the country's inoculation drive despite concerns over the Sinovac jab's effectiveness.

Brazil's health regulatory agency said Tuesday it had approved the Pfizer-BioNTech Covid-19 vaccine for widespread use, as the country races to secure enough doses to contain one of the world's worst outbreaks.

European Commission chief Ursula von der Leyen said Tuesday that coronavirus vaccines from Russia and China could be approved for use in the bloc if they "show all the data", lawmakers told AFP.

Pfizer and BioNTech, makers of a Covid-19 vaccine, said on Thursday that their product is effective against coronavirus variants that have emerged in Britain and South Africa.

The WHO and pharmaceuticals giant Pfizer on Friday announced a deal for up to 40 million initial doses of the Pfizer-BioNTech Covid-19 vaccine for poorer countries, through Covax global pool.

Israel said Sunday two million people will have received a two-dose Covid-19 vaccination by the end of January, a pace Prime Minister Benjamin Netanyahu boasts is the world's fastest.